Catalyst Pharmaceutical Partners (CPRX) PT Raised to $9 at Oppenheimer Following 'Pre-Launch' Call
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $9.00 (from $6.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
